medigraphic.com
ISSN 0035-0052 (Print)

2006, Number 1

<< Back Next >>

Rev Mex Pediatr 2006; 73 (1)

Bleeding frequency in the gastrointestinal tract at Neonatal Intensive Care Unit

Hernández YR, Avendaño DJM, Macías AHA

Language: Spanish
References: 16
Page: 5-8
PDF size: 51.41 Kb.


ABSTRACT

Objective. To know the frequency and factors implicated in gastrointestinal bleeding in neonates.
Material and methods. Two hundred and eighty five files of children assisted in an intensive therapy along with a year. Eighty two of them had bleeding. Information was collected about: gestational age, body weight at birth, Apgar, clinical diagnosis beside the bleeding, use of mechanical ventilation, orogastric feeding tube comorbidity, therapeutic management.
Results. The biggest frequency was in neonates below 1,500 g in the first week of life. The associated illnesses were: sepsis, breathing difficulty syndrome, use of drugs; when the diagnosis of bleeding was done. The variables implicated in the bleeding coincide with that reported by other authors.
Conclusions. The study confirmed the findings related to the factors associated to the gastrointestinal bleeding in neonates. Emphasis is done in regard to the frequency in children with lung ventilation and the use of some drugs.


REFERENCES

  1. Ardela DE. Hemorragia digestiva en el niño. Bol Pediatr 1998; 38: 204-6.

  2. Squires RH. Upper Gastrointestinal Hemorrhage. Pediatrics Review 1999; 20: 171-4.

  3. Squires RH. Gastrointestinal Bleeding. Pediatrics Review 1999; 20:95-8.

  4. Prieto BG, Carrasco GS, Lama MR, Polanco AI. Evaluación y diagnóstico de las hemorragias digestivas en niños. Acta Pediatr Esp 1989; 47: 293-8.

  5. Arens R. Gastrointestinal Bleeding: Surgical Perspective. www.EMedicine. June 13, 2004.

  6. Tryba M, Zevounou F, Torok M, Zenz M. Prevention of acute stress bleeding with sucralfate, antacids, or cimetidine. Am J Med 1985; 79(Suppl 2c): 55-61.

  7. Anday EK, Conway D. Steroid therapy in the high-risk Neonate: Benefits and risk. Clin Obstet Gynecol 2003; 46: 190-210.

  8. Goodman, Gilman’s. The pharmacological basis of therapeutics. ed. 9th New York: Macmillan. 1996: 965-80.

  9. Calabuig SM, Ramos EJM. Practical guides on gastroenterology. Bleeding of the upper and lower gastrointestinal tract. An Esp Pediatr 2002; 57: 466-79.

  10. Shuman RB, Schuster DP, Zuckerman GR. Prophylactic therapy for stress ulcer bleeding: A reappraisal. Ann Intern Med 1987; 106: 562-7.

  11. Lacroix J, Infante-Riverd C, Gauthier M, Rousseau E, Doesburg N. Upper gastrointestinal tract bleeding acquired in a pediatric intensive care unit: Prophylaxis trial with cimetidine. J Pediatric 1986; 108: 1015-8.

  12. Cochran EB, Phelps SJ, Tolley EA, Stidham GL. Prevalence and risk factors for upper gastrointestinal tract bleeding in critically ill pediatric patients. Crit Care Med 1992; 20(11): 1519-23.

  13. Adeyemi SD, Ein SH, Simpsom JS. Perforated stress ulcer in infants. Ann Surg 1979; 190: 706-8.

  14. Lacroix J, Infante-Riverd C, Jenicek M et al. Prophylaxis of upper gastrointestinal bleeding in intensive care units: A meta-analysis. Crit Care Med 1989; 17: 862-9.

  15. Alliet P, Raes M, Bruneel E, Gillis P. Omeprazole in infants with cimetidine-resistant peptic esophagitis. J Pediatr 1998; 132: 352-4.

  16. Kato S, Edina K, Fujiik A et al: Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity. J Pediatr 1996; 128: 415-21.




2020     |     www.medigraphic.com